Next-generation Neurostimulation Will Be “Predictive”
This article was originally published in The Gray Sheet
Executive Summary
"Predictive" stimulation that delivers electrical current at the onset of abnormal brain activity could distinguish the next generation of devices for treating drug-resistent movement and psychiatric disorders
You may also be interested in...
Neurotechnology Interests Form New Trade Association To Lobby Congress
A newly formed trade association called the Neurotechnology Industry Organization (NIO) will seek greater government support for the development of therapies for brain and nervous system diseases
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.